• Facebook
  • Twitter
  • Linkedin
Oslo Cancer Cluster - Innovation Park
  • About
    • A power centre
    • Board
    • Construction stage 2
  • Companies
  • News
  • Events
  • Property
    • Property Overview
    • The building
    • Leasing
    • Services
    • Floor plans
    • Technical solutions
    • Illustrations
  • Contact
  • Menu

Archive for: Company

You are here: Home / Property / Company

Syklotronsenteret

Zelluna

Ultimovacs

Logo Cancer Registry of Norway

The Norwegian Cancer Registry

Oslo Cancer Cluster

RADFORSK

Hospital Pharmacy Production Unit at oslo University Hospital

Oslo Hospital Pharmacy

Ullern Upper Secondary School

Oslo Cancer Cluster Incubator

Department of Pathology

Page 1 of 212

Pages

  • A power centre
  • About
  • Amenities
  • Board
  • Catering
  • Companies
  • Construction stage 2
  • Contact
  • Events
  • Feed-test
  • Home
  • News
  • Parking
  • Privacy notice
  • Property
  • startpage
  • Team

Categories

  • #OIW2017
  • 100 episodes
  • Acapo
  • Access to capital
  • advanced light microscopy
  • AI
  • Allison
  • anette weyergang
  • Arctic Pharma
  • arendalsuka19
  • Artemida
  • artificial intelligence
  • astrazeneca
  • award
  • AXL-kinase inhibitor
  • bemcentinib
  • BerGen Bio
  • bergenbio
  • bile duct cancer
  • BIO
  • biobanks
  • biochemistry
  • biotechnology
  • biotechs
  • bjørn klem
  • bladder cancer
  • BLC
  • board member
  • board members
  • breakfast meeting
  • Breast Cancer
  • Bristol-Myers Squibb
  • Business development
  • cancer
  • cancer care
  • cancer clusters
  • Cancer Crosslinks
  • Cancer Crosslinks 2019
  • cancer crosslinks 2020
  • cancer drug fund
  • cancer medicine
  • cancer patient
  • cancer patients
  • cancer research
  • cancer treatments
  • cancer vaccine
  • CAR T cells
  • car t therapy
  • CAR T-cell therapy
  • Cathrine M. Lofthus
  • CCB
  • cell biology
  • cell therapy
  • Centre for cancer biomedicine
  • cervical cancer
  • chemotherapy
  • clinical collaboration
  • clinical research
  • clinical study
  • clinical trial
  • Clinical Trial Unit
  • Clinical Trials
  • clusters
  • collaboration
  • conference
  • consulting
  • corona
  • curida
  • Dehns
  • digibcube
  • digitalisation
  • Digitalization
  • DNV GL
  • domore!
  • drug
  • Dynabeads
  • E-health
  • ECCP
  • education
  • educational agreement
  • EHIN
  • EHiN 2019
  • einarsson
  • Eisai
  • embassy of denmark
  • erc grant
  • European Cancer Cluster Partnering
  • evaluation
  • excellent
  • experimental cancer therapy
  • External
  • financial scheme
  • financing
  • forskerlinje
  • fund
  • funding
  • funding opportunity
  • genes
  • genomics
  • Giamag
  • Gunhild M. Mælandsmo
  • håkon haugli
  • health
  • Health data
  • health industry
  • health innovation
  • health mentor program
  • health services
  • health technology assessment
  • helsedata
  • helsementor
  • helsemyggordningen
  • Helsenæring
  • Helsenæringens verdi
  • hematology
  • Herceptin
  • Hexvix
  • Horizon 2020
  • HPV
  • HTA
  • ICCS
  • ICT
  • immun-oncology
  • immune
  • immune checkpoint inhibitor
  • Immunitrack
  • Immuno-Oncology
  • immunology
  • immunotherapy
  • iNANOD
  • Incubator
  • inkubator
  • Innovasjon Norge
  • Innovasjonsparken
  • innovation
  • innovation norway
  • InnovationPark
  • Institute for cancer research
  • International
  • Investinor
  • investment
  • investoropportunities
  • investors
  • IRW Consulting
  • iselin nybø
  • James Allison
  • Jon Amund Kyte
  • kaare norum
  • Kadycla
  • kaiku health
  • kapecitabine
  • Ketil Widerberg
  • KEYTRUDA
  • king hussein cancer centre
  • king hussein cancer foundation
  • Kirsten Sandvig
  • kongsberg beam technology
  • laboratory
  • lapatinib
  • life science
  • life talents
  • Logistics
  • lung cancer
  • Lytix Biopharma
  • Machine-learning
  • malignant melanoma
  • medical device
  • medical nutrition
  • meeting places
  • Melanoma
  • Members
  • mentor
  • mentorprogram
  • metastasis
  • MyHere
  • Nacamed
  • nanomedicine
  • Nansen prize
  • næringsdepartementet
  • nec corporation
  • neuroscience
  • New cancer research
  • new cancer treatment
  • new cancer treatments
  • new members
  • new memebers
  • News
  • NLS Days
  • nls days 2019
  • NLSDays
  • Nobel Prize
  • NOME
  • Nordic collaboration
  • Nordic Life Science Days
  • nordic nanovector
  • Norgenotech
  • norway
  • Norwegian Cancer Society
  • Norwegian research Council
  • olweus
  • oncoimmunity
  • Oncoinvent
  • oncology
  • oncology clinical trials
  • oncology conference
  • oncolytic peptide
  • OPINION
  • Oslo Cancer Cluster
  • Oslo Cancer Cluster Incubator
  • Oslo Cancer Cluster Innovation Park
  • Oslo Cancer Cluster Innovation Park. radiumhsopitalets legater
  • Oslo Cancer Cluster Innovationpark
  • oslo stock exchange
  • oslo university hospital
  • Other
  • Padmanee Sharma
  • pancreatic cancer
  • partnering
  • Partnership
  • pathology
  • patient involvement
  • patients
  • PCI
  • PCI Biotech
  • PCI technology
  • pdt
  • Per Morten Sandset
  • Permides
  • Personalis
  • personalised medicine
  • Personalized Cancer Medicine
  • personalized medicine
  • pharma-TV
  • pharmaconutrition
  • photocure
  • photodynamic technology
  • podcast
  • Precision Medicine
  • precision oncology
  • prediction tool
  • press seminar
  • prisvinnere
  • profag
  • project
  • Proton therapy
  • q3 report
  • R&D
  • R&D Network
  • R&D Network Meetings
  • radforsk
  • Radium
  • radium hospital
  • Radium Hospital Foundation
  • Radium Hospital Hospital
  • Radiumhospitalet
  • Report
  • research
  • research and development
  • resistant mechanism
  • revenue growth
  • Roche
  • Sanofi
  • Sarcoma
  • School collaboration
  • seminar
  • sharelab
  • simone mester
  • Siva
  • skin cancer
  • skolesamarbeid
  • smartfish
  • SPARK
  • SPARK Scholars
  • Stanford
  • start-up
  • Start-ups
  • startups
  • Statsbudsjettet
  • summer meeting
  • summer party
  • symptom monitoring
  • t cell
  • t cell therapy
  • Talents of Tomorrow
  • Targovax
  • tech
  • Thermo Fisher Scientific
  • third quarter
  • thomas andersson
  • tv
  • Ugelstad-kulene
  • uio
  • ullern
  • Ullern High School
  • Ullern Upper Secondary School
  • Ullern Videre
  • ullern videregående
  • ullern videregående skole
  • Ultimovacs
  • Uncategorized
  • university of oslo
  • Vaccibody
  • Venstre
  • warburg effect
  • WLC
  • workshop

Archive

  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • February 2014
  • January 2014
  • December 2013

CONTACT

Oslo Cancer Cluster Innovation Park
Ullernchauséen 64/66
0379 Oslo
Norway

Contact us >

Info

Oslo Cancer Cluster Innovation Park opened in May 2015.

The Innovation Park brings together the oncology-value chain from basic research to industry within the Oslo-area.

Our vision is to create Europe's leading environment for education, research and industry within oncology, shortening the development time of new cancer treatments.

About

  • A power centre
  • Board
  • Construction stage 2
To OCC
To Oslo Cancer Cluster Incubator
© Copyright - Oslo Cancer Cluster - Innovation Park - Organization number: 991068503 - Design by Fete Typer - Privacy notice and cookies
Scroll to top